Neurofibromatosis type 2 is most often diagnosed based on the presence of physical symptoms that are part of the specific diagnostic criteria for the disorder. Genetic testing for the NF2 mutation is ...
This month, I’d like to discuss the options that are available when an individual has clinical features of any of the three types of NF but genetic testing is negative. Next-generation sequencing (NGS ...
(RTTNews) - Recursion (RXRX) said that the U.S. Food and Drug Administration has granted the company Fast Track designation for the investigation of REC-2282 for treatment of patients with NF2-mutated ...
Researchers at the University of Plymouth are leading an innovative initiative to advance the study of meningiomas in NF2-related schwannomatosis (NF2-SWN). Meningiomas, often linked to the loss of ...
Hangzhou-headquartered Santo Therapeutics, which has a base at Stevenage Bioscience Catalyst, says its lead program, ST002, ...
Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial Eligible patients whose tumors ...
For patients with NF2-related schwannomatosis and progressive tumors, the ALK inhibitor brigatinib (Alunbrig) was associated with radiographic response for multiple tumor types, as well as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results